therapeutic areas
Novartis Reports Strong Financial Performance in 2024, Validating Pure-Play Strategy
Novartis, earnings, pure-play strategy, pharmaceutical industry, financial performance, R&D focus, core therapeutic areas
Actionable Insights Powered by AI
Novartis, earnings, pure-play strategy, pharmaceutical industry, financial performance, R&D focus, core therapeutic areas